CNBX Pharmaceuticals Inc. Quarterly Cost of Revenue in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
CNBX Pharmaceuticals Inc. quarterly Cost of Revenue history and growth rate from Q1 2015 to Q1 2024.
  • CNBX Pharmaceuticals Inc. Cost of Revenue for the quarter ending February 29, 2024 was $6.22K.
Cost of Revenue, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.22K +$6.22K Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-16
Q1 2023 $0 Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-16
Q1 2018 $0 $0 Dec 1, 2017 Feb 28, 2018 10-Q 2018-04-05
Q2 2017 $0 $0 Mar 1, 2017 May 31, 2017 10-Q 2017-07-17
Q1 2017 $0 $0 Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-05
Q2 2016 $0 $0 Mar 1, 2016 May 31, 2016 10-Q 2017-07-17
Q1 2016 $0 $0 Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-14
Q2 2015 $0 Mar 1, 2015 May 31, 2015 10-Q 2016-07-13
Q1 2015 $0 Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.